EUVIMEDEUVIMED entdecken
Studienprotokoll

L26/P-699 Modified natural frozen embryo transfer cycle is a simple and an effective frozen embryo transfer protocol in ovulatory patients

P. Cherouveim, E. Cetin, L. Clever, T. Abozaid, M. Fakih, M. Abuzeid

Human Reproduction · 01.07.2026 · 41 (Supplement_1)

DOI: 10.1093/humrep/deag083.1028 ↗

Kurz gefasst

Studienprotokoll in der Zeitschrift Human Reproduction, online erschienen am 08.07.2026. Verfasst von P. Cherouveim und 5 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Study question Do reproductive outcomes differ between modified natural cycle frozen embryo transfer (NC-FET) and hormonally controlled frozen embryo transfer (HC-FET) among ovulatory patients? Summary answer Among ovulatory patients, modified NC-FET is associated with higher clinical pregnancy, and delivery rates compared with HC-FET, without differences in miscarriage rates. What is known already FET can be performed using NC, modified NC, or HC. NC and modified NC can only be used in ovulatory patients. While programmed HC-FET offers scheduling convenience, it requires prolonged exogenous hormone exposure. Experts highlight that the window of implantation in programmed cycles hinges on the duration of progesterone exposure, and small deviations can impact implantation and pregnancy success. In current practice in ovulatory patients, clinicians typically choose between a NC or a modified NC, which leverages endogenous ovulation and luteal function, and a fully programmed regimen HC-FET. Evidence comparing these approaches specifically in ovulatory patients remains limited and inconsistent. Study design, size, duration Single-center retrospective cohort of 714 ovulatory patients undergoing 762 blastocyst-stage FET (636 modified NC-FET and 126 HC-FET cycles) between January 2006 and December 2024. Donor embryos and preimplantation genetic testing cycles were excluded. Outcomes included implantation, clinical pregnancy, miscarriage, and delivery rates. Generalized estimating equation regression accounted for multiple cycles per patient and adjusted for infertility type and number of embryos transferred. Analyses stratified by age (<35, 35–38, 38–40, >40 years). Participants/materials, setting, methods In modified NC-FET; HCG (10,000 IU) was administered on LH surge day, vaginal micronized progesterone starting 2 days later and blastocyst transfer 7 days later. In HC-FET; micronized estradiol 2mg vaginally (T.I.D) and estradiol patches 0.1mg (every third day), beginning cycle day 2 or 3 (with/without gonadotropin-releasing hormone agonist), Progesterone in oil 100 mg intramuscularly was started when endometrial thickness >8 mm and serum estradiol >500 pg/ml. Blastocyst transfer performed on progesterone triggering day 6. Main results and the role of chance Overall there were no significance differences in baseline characteristics between the patients in both protocols, except for lower incidence of primary infertility (36.3% vs. 46.8%, p = 0.030), and higher incidence of single blastocyst transfers (32.2% vs. 22.5%, p = 0.001) in modified NC-FET compared to HC-FET. There were no significant differences in miscarriage rates (4.0% vs. 3.7%, p = 0.917). NC-FET had higher implantation rates (49.9% vs. 30.5%, p = 0.002), clinical pregnancy rates (58.8% vs. 42.1%, p = 0.001) and delivery rates (51.9% vs. 37.3%, p = 0.003). Results remained significant after adjustment [adjusted OR (95%CI): Clinical pregnancy: 2.04(1.34-3.10), p = 0.001; Delivery: 1.90 (1.24-2.90), p = 0.003]. After stratification by age, similar unadjusted [Clinical pregnancy rates: 64.9% vs. 40.0%, p = 0.001; Delivery rates: 58.0% vs. 35.0%, p = 0.001] and adjusted results [adjusted OR (95%CI): Clinical pregnancy: 2.90 (1.58-5.33), p = 0.001; Delivery: 2.52 (1.38-4.59), p = 0.003] were noted in the <35 years old subgroup. No significant differences were noted in the rest of the outcomes, before and after adjustment and/or stratification by age. Limitations, reasons for caution The retrospective design introduces potential residual confounding, and protocol selection was not randomized. Wider implications of the findings In ovulatory patients, modified NC-FET offers a less invasive, more patient-friendly approach without compromising—and potentially improving—reproductive outcomes compared with HC-FET, supporting physiology-aligned individualized FET strategies. Trial registration number No

Zitieren

APA

Cherouveim, P., Cetin, E., Clever, L., Abozaid, T., Fakih, M., & Abuzeid, M. (2026). L26/P-699 Modified natural frozen embryo transfer cycle is a simple and an effective frozen embryo transfer protocol in ovulatory patients. Human Reproduction, 41(Supplement_1). https://doi.org/10.1093/humrep/deag083.1028

Vancouver

Cherouveim P, Cetin E, Clever L, Abozaid T, Fakih M, Abuzeid M. L26/P-699 Modified natural frozen embryo transfer cycle is a simple and an effective frozen embryo transfer protocol in ovulatory patients. Human Reproduction. 2026;41(Supplement_1). doi:10.1093/humrep/deag083.1028

BibTeX
@article{Cherouveim2026,
  author = {Cherouveim, P. and Cetin, E. and Clever, L. and Abozaid, T. and Fakih, M. and Abuzeid, M.},
  title = {L26/P-699 Modified natural frozen embryo transfer cycle is a simple and an effective frozen embryo transfer protocol in ovulatory patients},
  journal = {Human Reproduction},
  year = {2026},
  volume = {41},
  number = {Supplement_1},
  doi = {10.1093/humrep/deag083.1028}
}
Kostenlos starten →